🇺🇸 poliovirus vaccine in United States

39 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 39

Most-reported reactions

1. Diarrhoea — 6 reports (15.38%)
2. Foetal Exposure During Pregnancy — 5 reports (12.82%)
3. Pyrexia — 5 reports (12.82%)
4. Cough — 4 reports (10.26%)
5. Viral Infection — 4 reports (10.26%)
6. Atrial Septal Defect — 3 reports (7.69%)
7. Covid-19 — 3 reports (7.69%)
8. Decreased Appetite — 3 reports (7.69%)
9. Nasopharyngitis — 3 reports (7.69%)
10. Upper Respiratory Tract Infection — 3 reports (7.69%)

Source database →

Frequently asked questions

Is poliovirus vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for poliovirus vaccine in United States?

Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control is the originator. The local marketing authorisation holder may differ — check the official source linked above.